stockportfolio.pro
Stocks / BME vs GLRE
BME vs GLRE
BlackRock Health Sciences Trust and Greenlight Capital Re, Ltd. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Financial Services.
| BlackRock Health Sciences Trust (BME) | Greenlight Capital Re, Ltd. (GLRE) | |
|---|---|---|
| Market cap | $0.5B | $0.5B |
| Revenue (latest FY) | $77.54M | $683.21M |
| Net income (latest FY) | $76.97M | $74.83M |
| Revenue growth (5y CAGR) | — | 7.1% |
| Net margin | 99.3% | 11.0% |
| Return on equity | 13.5% | 10.6% |
| P/E ratio | 6.9 | 6.8 |
| Dividend yield | 7.8% | — |
| Profitable years (of last 10) | 3 | 7 |
| Positive free cash flow | — | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BME — free Open GLRE — freeFrequently asked questions
Which is bigger, BME or GLRE?
Greenlight Capital Re, Ltd. is larger by market capitalization — $0.5B versus $0.5B.
Which grows faster, BME or GLRE?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.